Therapeutic process for the treatment of obesity and associated metabolic disorders
OwnerAnthony Cincottainventor
Life of this patent
Estimating the term…
Abstract
The present invention is directed to a method of treating a patient suffering from the metabolic syndrome and/or related disorders including Type 2 diabetes, comprising the steps of (a) providing to the patient a dietary regimen that decreases overactive sympathetic tone; followed by (b) providing to the patient a dietary regimen that increases dopaminergic tone while maintaining the above decreased overactive sympathetic tone. The present invention is also directed to prepackaged meals and recipes useful in implementing the dietary regimens.
Claims28
A method of treating a patient suffering from the metabolic syndrome and/or related disorders, comprising the steps of:
- (a) providing to said patient a dietary regimen that decreases overactive sympathetic tone;
- followed by
- (b) providing to said patient a dietary regimen that increases dopaminergic tone while maintaining said decreased overactive sympathetic tone.
An article of manufacture comprising packaging material and one or more food products contained within said packaging material, wherein said one or more food products are effective for decreasing overactive sympathetic tone and wherein said packaging material comprises a label which indicates that said one or more food products can be used for treating the metabolic syndrome and/or related disorders in a patient, and wherein said one or more food products are selected from the group consisting of:
- 1) protein of about 25%±5% of total daily caloric intake of said patient;
- 2) monounsaturated fat of about 25%±5% of total daily caloric intake of said patient;
- 3) saturated fat of about 5%±5% of total daily caloric intake of said patient;
- 4) polyunsaturated fat of about 3%±5% of total daily caloric intake of said patient;
- and
- 5) complex carbohydrate of about 42%±7% of total daily caloric intake of said patient;
- and combinations thereof.
An article of manufacture comprising packaging material and one or more food products contained within said packaging material, wherein said one or more food products are effective for increasing dopaminergic tone while maintaining decreased overactive sympathetic tone, and wherein said packaging material comprises a label which indicates that said one or more food products can be used for treating the metabolic syndrome and/or related disorders in a patient, and wherein said one or more food products are selected from the group consisting of:
- 1) protein of about 24%±5% of total daily caloric intake of said patient;
- 2) monounsaturated fat of about 23%±5% of total daily caloric intake of said patient;
- 3) saturated fat of about 5%±5% of total daily caloric intake of said patient;
- 4) polyunsaturated fat of about 3%±5% of total daily caloric intake of said patient;
- 5) complex carbohydrate of about 45%±5% of total daily caloric intake of said patient;
- 6) L-DOPA-containing food in an amount sufficient to ingest about 25-400 mg. of L-DOPA per day;
- and combinations thereof.
Dependencies are inferred from the claim text.